Clinical Trials Logo
  1. Home
  2. FSGS
  3. NCT01451489

The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis — FSGS  

FSGS Clinical Trial

Official title:
A Randomized,Multicentre,Prospective Study on the Tacrolimus(FK506)for Focal Segmental Glomerulosclerosis

Clinical Trial Summary

This is a prospective,multicentre study to compare the efficacy, safety, tolerability and relapse of FK506 versus CTX in the treatment of severe Focal Segmental Glomerulosclerosis (FSGS).

Clinical Trial Description

1. Using the response rate and completely response time to compare the efficacy of FK506 versus CTX therapy for the severe FSGS patients.

2. To compare the safety and tolerability of FK506 versus CTX for the severe FSGS patients. ;

Study Design

Related Conditions & MeSH terms

  • FSGS
  • Glomerulosclerosis, Focal Segmental
Clinical Trial Details
NCT number NCT01451489
Study type Interventional
Source Nanjing University School of Medicine
Contact
Status Terminated
Phase N/A
Start date October 13, 2011
Completion date October 29, 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT04009668 - Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease Phase 2
Recruiting NCT05183646 - A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB Phase 3
Completed NCT03536754 - A Study of CCX140-B in Subjects With FSGS Phase 2
Withdrawn NCT02399462 - Acthar for Treatment of Post-transplant FSGS Phase 4
Enrolling by invitation NCT04571658 - NEPTUNE Match Study
Recruiting NCT01468493 - A Prospective Controlled Study of Serum suPAR in the CsA-treated FSGS Patients N/A
Recruiting NCT05508009 - Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor Phase 1/Phase 2
Terminated NCT01164098 - Rituximab to Prevent Recurrence of Proteinuria Phase 3
Active, not recruiting NCT02683889 - Use of Acthar in Patients With FSGS That Will be Undergoing Renal Transplantation Phase 3
Recruiting NCT05650619 - Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
Recruiting NCT05383547 - Bortezomib for Treating Glomerular Diseases N/A
Recruiting NCT05505500 - Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.